MAPK signaling in inflammation-associated cancer
development
Pengyu Huang1,Lijian Hui1,Jiahuai Han2,
Author information+
1.Laboratory of Molecular
Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai
Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai
200031, China; 2.Key Laboratory of the
Ministry of Education for Cell Biology and Tumor Cell Engineering,
School of Life Sciences, Xiamen University, Xiamen 361005, China;
Show less
History+
Published
01 Mar 2010
Issue Date
01 Mar 2010
Abstract
Mitogen-activated protein (MAP) kinases comprise a family of protein-serine/threonine kinases, which are highly conserved in protein structures from unicellular eukaryotic organisms to multicellular organisms, including mammals. These kinases, including ERKs, JNKs and p38s, are regulated by a phosphorelay cascade, with a prototype of three protein kinases that sequentially phosphorylate one another. MAPKs transduce extracellular signals into a variety of cellular processes, such as cell proliferation, survival, death, and differentiation. Consistent with their essential cellular functions, MAPKs have been shown to play critical roles in embryonic development, adult tissue homeostasis and various pathologies. In this review, we discuss recent findings that reveal the profound impact of these pathways on chronic inflammation and, particularly, inflammation-associated cancer development.
Pengyu Huang, Lijian Hui, Jiahuai Han,.
MAPK signaling in inflammation-associated cancer
development. Protein Cell, 2010, 1(3): 218‒226 https://doi.org/10.1007/s13238-010-0019-9
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
This is a preview of subscription content, contact us for subscripton.
AI Summary 中Eng×
Note: Please note that the content below is AI-generated. Frontiers Journals website shall not be held liable for any consequences associated with the use of this content.